Scientific paper - Original scientific paper
Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance
Molecular and Clinical Oncology, 11 (2019), 6; 563-572. https://doi.org/10.3892/mco.2019.1936


Cite this document

Bukovac, A., Kafka, A., Hrašćan, R., Vladušić, T. & Pećina‑Šlaus, N. (2019). Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance. Molecular and Clinical Oncology, 11. (6), 563-572. doi: 10.3892/mco.2019.1936

Bukovac, Anja, et al. "Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance." Molecular and Clinical Oncology, vol. 11, no. 6, 2019, pp. 563-572. https://doi.org/10.3892/mco.2019.1936

Bukovac, Anja, Anja Kafka, Reno Hrašćan, Tomislav Vladušić and Nives Pećina‑Šlaus. "Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance." Molecular and Clinical Oncology 11, no. 6 (2019): 563-572. https://doi.org/10.3892/mco.2019.1936

Bukovac, A., et al. (2019) 'Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance', Molecular and Clinical Oncology, 11(6), pp. 563-572. doi: 10.3892/mco.2019.1936

Bukovac A, Kafka A, Hrašćan R, Vladušić T, Pećina‑Šlaus N. Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance. Molecular and Clinical Oncology [Internet]. 2019 October 15 [cited 2023 January 27];11(6):563-572. doi: 10.3892/mco.2019.1936

A. Bukovac, A. Kafka, R. Hrašćan, T. Vladušić and N. Pećina‑Šlaus, "Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance", Molecular and Clinical Oncology, vol. 11, no. 6, pp. 563-572, October 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:486486. [Accessed: 27 January 2023]

Please login to the repository to save this object to your list.